Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2209104-84-5
2. Hsk-16149
3. Q3mk7e8686
4. Refchem:1082256
5. Hsk16149
6. Crisugabalina
7. Crisugabaline
8. Crisugabalin [inn]
9. Crisugabalin [who-dd]
10. Orb1689753
11. Chembl5314958
12. Schembl21144566
13. Gtpl13764
14. Ex-a10679
15. Da-74294
16. Hy-142240
17. Cs-0371489
18. (1s,2s,3r,6s,8s)-2-(aminomethyl)tricyclo[4.2.1.03,8]nonane-2-acetic Acid
19. 2-((1s,2s,3r,6s,8s)-2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetic Acid
20. 2-[(1s,2s,3r,6s,8s)-2-(aminomethyl)-2-tricyclo[4.2.1.03,8]nonanyl]acetic Acid
21. Tricyclo[4.2.1.03,8]nonane-2-acetic Acid, 2-(aminomethyl)-, (1s,2s,3r,6s,8s)-
| Molecular Weight | 209.28 g/mol |
|---|---|
| Molecular Formula | C12H19NO2 |
| XLogP3 | -0.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 63.3 |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 304 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
33
PharmaCompass offers a list of Crisugabalin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Crisugabalin manufacturer or Crisugabalin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Crisugabalin manufacturer or Crisugabalin supplier.
A Crisugabalin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Crisugabalin, including repackagers and relabelers. The FDA regulates Crisugabalin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Crisugabalin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Crisugabalin supplier is an individual or a company that provides Crisugabalin active pharmaceutical ingredient (API) or Crisugabalin finished formulations upon request. The Crisugabalin suppliers may include Crisugabalin API manufacturers, exporters, distributors and traders.
Crisugabalin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Crisugabalin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Crisugabalin GMP manufacturer or Crisugabalin GMP API supplier for your needs.
A Crisugabalin CoA (Certificate of Analysis) is a formal document that attests to Crisugabalin's compliance with Crisugabalin specifications and serves as a tool for batch-level quality control.
Crisugabalin CoA mostly includes findings from lab analyses of a specific batch. For each Crisugabalin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Crisugabalin may be tested according to a variety of international standards, such as European Pharmacopoeia (Crisugabalin EP), Crisugabalin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Crisugabalin USP).
